Why Zeltiq Aesthetics (ZLTQ) Stock Hit A Six Month High Today

NEW YORK (TheStreet) -- Shares of Zeltiq Aesthetics  (ZLTQ) are surging 30.56% to $21.66, hitting a six month high today, after releasing positive second quarter earnings and an upbeat full year outlook, helped by increasing momentum in CoolSculpting sales, its fat cell removal devices.

The company reported net income for the second quarter of 2014 of $2.8 million, or 7 cents per share, up from a net loss of $3.6 million, or -10 cents per share in the same quarter the previous year, and beating analysts' consensus estimate of -13 cents by 20 cents.

Revenue for the second quarter was up 79.1% from the same quarter of 2013 at $47.1 million, beating the consensus estimate of $34.93 million.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The medical device development company increased its full year 2014 revenue guidance to $160 million and $165 million, up from the prior $137 million to $140 million, and more than the consensus of $140.1 million.

ZLTQ ChartZLTQ data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

2 Small Biotechs Under $5 May Be Bargains

Small-Cap Turnaround Stories

Allergan, Celgene Offer Solid Biotech Value

Allergan, Celgene Offer Solid Biotech Value

Allergan, Celgene Offer Solid Biotech Value